Khaled Attia Selected Research

Histamine Agonists

1/2022

Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D2 and Histamine H3 Receptors: A PET Study in Healthy Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khaled Attia Research Topics

Disease

1	Ovarian Cysts (Ovarian Cyst) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Neurobehavioral Manifestations 01/2022
1	Bone Diseases (Bone Disease) 07/2019
1	Neoplasms (Cancer) 03/2005
1	Breast Neoplasms (Breast Cancer) 03/2005
1	Hypoxia (Hypoxemia) 03/2005

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2022 - 03/2005
1	Placental HormonesIBA 01/2022
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2022
1	Histamine AgonistsIBA 01/2022
1	6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA 01/2022
1	MineralsIBA 07/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2005

Therapy/Procedure

1	Renal Dialysis (Hemodialysis) 07/2019
1	Drug Therapy (Chemotherapy) 03/2005
1	Neoadjuvant Therapy 03/2005